Table 2.

Emerging and investigational therapies for the treatment of influenza (adapted from Patroniti et al. [71])

Therapy requiring continued investigation	Therapy associated with adverse outcome
N-acetylcysteine [101] Polymyxin B-immobilised fibre column hemoperfusion [102] Therapeutic plasma exchange [103] Statins [104–106] Macrolides [107] Nitazoxanide (phase III) [1] DAS 181 (Fludase; phase II) [85]	Systemic corticosteroids [82–84, 108]